▼ SELL
$ Value
$214K
Shares
15,394
Price
$14
Filed
Mar 13
Insider
Name
GRIFFIN MICHELLE RENEE
Title
—
CIK
0001229765
Roles
Director
Transaction Details
Transaction Date
2026-03-11
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
15,625
Footnotes
The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $13.84 to $13.96, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
Filing Info
GRIFFIN MICHELLE RENEE's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-11 | ADPT | ▼ | $214K |
| 2026-03-04 | ADPT | A | $0 |
| 2026-03-03 | ADPT | M | $192K |
| 2026-03-03 | ADPT | ▼ | $735K |
| 2026-03-03 | ADPT | M | $0 |
Other Insiders at ADPT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| GRIFFIN MICHELLE RENEE | — | $735K | 2026-03-04 |
| NEUPERT PETER M | — | — | 2026-03-04 |
| HERSHBERG ROBERT | — | — | 2026-03-04 |
|
ROBINS CHAD M
CEO and Chairman
|
— | $18.6M | 2026-04-08 |
|
LO FRANCIS
Chief People Officer
|
— | $1.3M | 2026-04-08 |
|
PISKEL KYLE
Chief Financial Officer
|
— | $286K | 2026-03-11 |
|
RUBINSTEIN JULIE
President and COO
|
— | $12.3M | 2026-04-21 |
|
ROBINS HARLAN S
Chief Scientific Officer
|
— | $7.5M | 2026-04-08 |
|
BENZENO SHARON
Chief Commercial Ofc Imm Med
|
— | $831K | 2026-03-11 |
|
BOBULSKY SUSAN
Chief Commercial Officer, MRD
|
— | $544K | 2026-03-11 |
| OWEN KATEY EINTERZ | — | — | 2026-03-04 |